Press
He
Weizmann Wonder Wander
Science news and culture
Search
echo t('Click') ?>
X
Menu
Home Page
Area of Research
Math & Computer Science
People
Space & Physics
Chemistry
Life Sciences
Environment
Science Teaching
Scientific Archaeology
Technology & Applications
The Campus
The Website
For Journalists
RSS Service
Subscribe to our monthly newsletter/press releases
He
Skip to Home
Skip to Search
Skip to Content
Skip to Contact us
Skip to Sitemap
Skip to Accessibility Statement
Press Releases
All Press Releases
Receive Press Releases
RSS
News
Top Stories
Subscribe to our Monthly Newsletter
Explore Topics
Math and Computer Science
Space and Physics
Chemistry
Life Sciences
Environment
More
Scientific Archaeology
Science Teaching
Technology & Applications
People and Events
Awards and Appointments
People
Events
Science on Tap
Conferences
On Campus
Art on Campus
All People and Events
Multimedia
The Beauty of Science
Videos and Lectures
Nano Comics
Around Campus
More
Publications
Special Issues
Blue Sky Research
Planting Knowledge
100 Milestones in Physics
Art on Campus
All Special Issues
Buildings on Campus
What the Tree Has
Weizmann International Magazine of Science and People
About
About the Weizmann Institute of Science
Facts and Figures
Dr. Chaim Weizmann
Visit the Weizmann Institute of Science
Follow Us
Are you a journalist?
Please sign up here for our press releases
Subscribe to our monthly newsletter:
First name
Last name
Email
*
Agreement
*
I agree to the
Terms of Use
and
Cookie & Privacy Policy
You are here
Home
>
Topics
>
Technology & Applications
> Diagnostic Techniques and Drugs
Diagnostic Techniques and Drugs
Technology & Applications
Yeda Technology Transfer
Benefiting Humanity
Biotechnology
Diagnostic Techniques and Drugs
Weizmann Institute of Science Announces Visiting Scientist Agreement with Pfizer Inc.
05.06.2016
Technology & Applications
,
Yeda Technology Transfer
,
Benefiting Humanity
,
Diagnostic Techniques and Drugs
The Weizmann Institute of Science in Rehovot, Israel, and Yeda Research and Development Co., Ltd., its commercial arm, announced this week that they...
One Patent, Three Drugs
16.03.2016
Cancer
,
Immunology
,
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
Portrazza is approved to by the US FDA to treat lung cancer
Merck and Weizmann Institute Sign New Framework Agreement on Research Collaboration
16.02.2016
Yeda Technology Transfer
,
Biotechnology
,
Diagnostic Techniques and Drugs
Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, by signing a new...
Weizmann Institute Drug, TOOKAD® Soluble, Approved for Prostate Cancer Therapy in Mexico
04.01.2016
Life Sciences
,
Biochemistry
,
Cancer
,
Disease, Drugs & Diagnostics
,
Yeda Technology Transfer
,
Biotechnology
,
Diagnostic Techniques and Drugs
Weakness into Strength
27.10.2014
Brain & Behavior
,
Chemistry
,
Diagnostic Techniques and Drugs
An MRI method for picking up the faintest signals can reveal the workings of the brain
Cell on a Chip Reveals Protein Behavior
18.03.2013
Molecular and Cell Biology
,
Genetics
,
Nanoscience
,
Materials Science
,
Diagnostic Techniques and Drugs
In the future, artificial cells may produce complex protein structures on demand
A Fragile Equilibrium
16.12.2012
Viruses & Microorganisms
,
Immunology
,
Disease, Drugs & Diagnostics
,
Bioinformatics and Computational Biology
,
Diagnostic Techniques and Drugs
A mathematical model may lead to safer chemotherapy
Copaxone® - MS medication
10.10.2010
Benefiting Humanity
,
Diagnostic Techniques and Drugs
from the institute to Teva Pharmaceuticals Ltd.
The Interferon Story
05.06.2007
Biochemistry
,
Molecular and Cell Biology
,
Genetics
,
Chemistry
,
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
Interferon-based drugs are a multi-billion dollar industry, used for treatment of viral diseases such as hepatitis, some cancers, and multiple...
BioLineRx In-Licenses Two Additional Drug Candidates
26.03.2007
Technology & Applications
,
Yeda Technology Transfer
,
Diagnostic Techniques and Drugs
Company expands therapeutic pipeline to fourteen by signing four in-licensing agreements in 2007
Pages
« first
‹ previous
1
2
3
4
5
6
7
next ›
last »
Top Stories
See All >
Dumpster Diving in Cancer Tissue Uncovers an Immune Evasion Mechanism
Human Embryo Models Grown from Stem Cells
Unlocking a Secret Nerve Cell Regenerator
Surviving on an Empty Battery
Press Releases
See All >
06.09.2023
Human Embryo Models Grown from Stem Cells
17.08.2023
Surviving on an Empty Battery
14.08.2023
A “Jupiter” Hotter than the Sun
Accessibility Toolbar
❌
+
Enlarge text
-
Reduce text
Monochrome
Contrast
Underline Links
Reset
Accessibility Statement